(Q45173736)

10 December 2017

title

Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate (English)

1 reference

10 December 2017

1 reference

Mats Hardling

1

1 reference

10 December 2017

Yuan Wei

2

1 reference

10 December 2017

Lars Palmqvist

3

1 reference

10 December 2017

Birgitta Swolin

4

1 reference

10 December 2017

Dick Stockelberg

5

1 reference

10 December 2017

Bengt Gustavsson

6

1 reference

10 December 2017

Kerstin Ekeland-Sjöberg

7

1 reference

10 December 2017

Hans Wadenvik

8

1 reference

10 December 2017

Anne Ricksten

9

1 reference

10 December 2017

publication date

1 January 2004

1 reference

10 December 2017

1 reference

10 December 2017

volume

21

1 reference

10 December 2017

issue

4

1 reference

10 December 2017

page(s)

349-358

1 reference

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

10 December 2017

cites work

1 reference

12 December 2020

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

1 reference

12 December 2020

Cytogenetic studies in patients on imatinib

1 reference

12 December 2020

Fudenine, a C-terminal truncated rat homologue of mouse prominin, is blood glucose-regulated and can up-regulate the expression of GAPDH

1 reference

12 December 2020

Serial monitoring of BCR-ABL by peripheral blood real-time polymerase chain reaction predicts the marrow cytogenetic response to imatinib mesylate in chronic myeloid leukaemia

1 reference

12 December 2020

Clinical decisions for chronic myeloid leukemia in the imatinib era.

1 reference

12 December 2020

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

12 December 2020

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

12 December 2020

The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemia

1 reference

12 December 2020

Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics

1 reference

12 December 2020

Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML St

1 reference

12 December 2020

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

12 December 2020

Quantification of bcr/abl mRNA expression by a rapid real-time reverse transcription-polymerase chain reaction assay in patients with chronic myeloid leukemia

1 reference

12 December 2020

A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia

1 reference

12 December 2020

Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia

1 reference

12 December 2020

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

12 December 2020

Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a 'real time' quantitative RT-PCR assay

1 reference

12 December 2020

Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase

1 reference

12 December 2020

Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia

1 reference

12 December 2020

Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation

1 reference

12 December 2020

Manifold-assisted reverse transcription-PCR with real-time detection for measurement of the BCR-ABL fusion transcript in chronic myeloid leukemia patients

1 reference

12 December 2020

Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon-alpha therapy

1 reference

12 December 2020

Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

1 reference

12 December 2020

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

12 December 2020

Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation

1 reference

12 December 2020

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

1 reference

12 December 2020

Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity

1 reference

12 December 2020

Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa

1 reference

12 December 2020

Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method

1 reference

12 December 2020

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

12 December 2020

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

12 December 2020

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:21:4:349

1 reference

Dimensions Publication ID

10 December 2017

1009507830

0 references

1 reference